Monday, August 15, 2016 8:38:48 AM
"Bleeding during skin surgery
Risk factors for excessive bleeding include:
Blood clotting abnormalities: low platelet count, low clotting factors (as occurs in liver failure), haemophilia, von Willebrand disease
Medications: aspirin, clopidogrel, warfarin, dipyridamole, heparin, dabigatran
Over-the-counter preparations: fish oil, garlic, ginko, ginseng, vitamin E, Dong quai, feverfew, resveratrol
Surgical site: forehead, scalp and eyelids often bruise more than other sites.
A small amount of bleeding and bruising can be expected. Your surgeon will try to minimise this as much as possible during the procedure by either clotting small vessels using electrosurgery (cautery) or tying off bleeding vessels with a stitch / suture.
http://www.dermnetnz.org/topics/risks-and-complications-of-skin-surgery/#blg
" On a randomized basis, one lesion received AC5 and the other(s) received a control treatment consisting of standard therapy plus a sham.
http://ir.archtherapeutics.com/press-releases/detail/477
LEGEND OF ABBREVIATIONS
B = Brilacidin, the antibiotic
K = Kevetrin, the oncology drug
P = Prurisol, the psoriasis drug
SAE = Serious Adverse Event
IND = Investigational New Drug
Recent ARTH News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/13/2024 10:18:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 09:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 09:00:11 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM